AbbVie shares retreated from a 10.6% gain over six sessions, closing at $251.13 after a recent acquisition-driven surge.
AbbVie (ABBV) shares fell 1.3% to $251.13 on Tuesday, halting a six-session winning streak. The decline followed a 10.6% gain over the prior six days, including a 6% jump after the company announced an acquisition.
The stock’s rally was driven by investor optimism surrounding the deal, which had lifted shares sharply in recent sessions. Prior to the streak, ABBV had traded with mixed momentum amid broader sector volatility.
No immediate market reaction details were provided following the day’s decline.